G. Milton Shy Visiting Professorship
The G. Milton Shy Visiting Professorship was established in honor of the memory and accomplishments of Dr. Milton Shy, who passed away on September 25, 1967, at the age of 47. It is a joint week-long professorship at the NIH, University of Pennsylvania and Columbia University.
Dr. G. Milton Shy received his MD from the University of Oregon and completed his medical training at the National Hospital at Queen Square in London and the Montreal Neurological Institute of McGill University. He began his academic career as an Assistant Professor of Neurology at the University of Colorado and while there also accepted the challenge of becoming the first Clinical Director of the National Institute of Neurological Diseases and Blindness (NINDB), now the National Institute of Neurologic Disorders and Stroke (NINDS). During his 10 years at the NINDB he established many traditions of scholarship–one of which was the welcoming of visiting scientists from anywhere in the world for collaborative work.
Dr. Shy made numerous critical contributions to research – in his lab, through his service on the study sections of the NINDB, and as a member of the Editorial Board of Neurology. He was a pioneer in using electron microscopy to study muscle diseases and is credited with discovering five previously unrecognized diseases: central core disease, magaconial myopathy, pleoconial myopathy, myotubular myopathy and nemaline myopathy. His research was not limited to neuromuscular disorders; he also advanced radioisotopic localization of brain tumors and described the association of central nervous system disease and orthostatic hypotension –leading to the eponym Shy-Drager syndrome.
Dr. Shy’s devotion to scientific inquiry was matched by his passion for patient care. He demanded and provided an uncompromising standard of excellence. With apparently inexhaustible energy, he was also fiercely dedicated to education -becoming an inspiration to students, residents and staff of all the medical schools in the area.
Dr. Shy was lost at the height of his creativity but his legacy lives on –his former residents and fellows (and his Columbia-trained son, Michael Shy) now fill dozens of full-time academic appointments in neurology throughout the world.
2026 Lecture Information:
The New Era of ALS Therapeutics
Date: June 12, 2026
Time: 1:15 - 2:15 PM
Location: Neurological Institute Auditorium, 710 West 168th Street, 1st Floor
Merit E. Cudkowicz, MD, MSc
Julieanne Dorn Professor of Neurology, Harvard Medical School
Executive Director, Mass General Brigham Neuroscience Institute
Dr. Merit Cudkowicz is the inaugural Executive Director of the Mass General Brigham Neuroscience Institute, Former Chair of Neurology and current Director of the Sean M. Healey & AMG Center for ALS at Mass General Hospital and the Julieanne Dorn Professor of Neurology at Harvard Medical School. Dr. Cudkowicz is one of the founders and former co-directors of the Northeast ALS Consortium (NEALS), a group of over 150 clinical sites in the United States, Canada, Europe and the Middle East dedicated to performing collaborative academic-led clinical trials and research studies in ALS. She is leading the first Platform Trial initiative in ALS and is also the Principal Investigator of the Clinical Coordination Center for the National Institute of Neurological Disorders and Stroke’s Neurology Network of Excellence in Clinical Trials (NeuroNEXT). She is a member of the National Academy of Medicine, American Association of Physicians and board member for the American Brain Foundation and American Neurological Association. Dr. Cudkowicz provides mentorship to physicians globally in careers in experimental therapeutics.